GnRH antagonists in ovarian stimulation for ICSI with oocyte restriction: a matched, controlled study

The probability of abnormal preimplantation development can be predicted by a single static observation on pronuclear stage morphology

Jan Tesařík · Human Reproduction · 1999 · 442 citations · Full text

Life Sciences, Developmental Biology, Embryogenesis +16

Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility

Gabriëlle J Scheffer, Frank J. Broekmans, M. Dorland et al. · Fertility and Sterility · 1999 · 389 citations · Full text

Medicine, Gynecology, Obstetrics +16

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin

Carola Albano, R. Felberbaum, Johan Smitz et al. · Human Reproduction · 2000 · 312 citations · Full text

Veterinary Medicine, Endocrinology, Gynecology +13

A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study group

Human Reproduction · 1998 · 293 citations · Full text

Pharmacy, Endocrinology, Pharmacology +17

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin)

F. Olivennes, J. Belaïsch-Allart, Jean-Claude Emperaire et al. · Fertility and Sterility · 2000 · 257 citations · Full text

Veterinary Medicine, Obstetrics, Pharmacology +17